Stada Group to buy Biopharma's prescription, consumer health

Biopharma shareholders will retain the company’s plasma business.

2 December 2019•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.